Alberto E. Musto, M.D.,Ph.D. - Publications

Affiliations: 
Eastern Virginia Medical School, Norfolk, VA, United States 
Area:
Epilepsy, epileptogenesis, glioblastoma multiforme, neuroinflammation

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Jean G, Carton J, Haq K, Musto AE. The role of dendritic spines in epileptogenesis. Frontiers in Cellular Neuroscience. 17: 1173694. PMID 37601280 DOI: 10.3389/fncel.2023.1173694  0.75
2023 Ots HD, Anderson T, Sherrerd-Smith W, DelBianco J, Rasic G, Chuprin A, Toor Z, Fitch E, Ahuja K, Reid F, Musto AE. Scoping review of disease-modifying effect of drugs in experimental epilepsy. Frontiers in Neurology. 14: 1097473. PMID 36908628 DOI: 10.3389/fneur.2023.1097473  0.718
2022 Ots HD, Tracz JA, Vinokuroff KE, Musto AE. CD40-CD40L in Neurological Disease. International Journal of Molecular Sciences. 23. PMID 35456932 DOI: 10.3390/ijms23084115  0.69
2021 Pototskiy E, Vinokuroff K, Ojeda A, Major CK, Sharma D, Anderson T, Howard K, Borenstein R, Musto AE. Author Correction: Downregulation of CD40L-CD40 attenuates seizure susceptibility and severity of seizures. Scientific Reports. 11: 23252. PMID 34824309 DOI: 10.1038/s41598-021-02005-8  0.755
2021 Pototskiy E, Vinokuroff K, Ojeda A, Major CK, Sharma D, Anderson T, Howard K, Musto AE. Downregulation of CD40L-CD40 attenuates seizure susceptibility and severity of seizures. Scientific Reports. 11: 17262. PMID 34446808 DOI: 10.1038/s41598-021-96760-3  0.763
2021 Pototskiy E, Dellinger JR, Bumgarner S, Patel J, Sherrerd-Smith W, Musto AE. Brain injuries can set up an epileptogenic neuronal network. Neuroscience and Biobehavioral Reviews. PMID 34384843 DOI: 10.1016/j.neubiorev.2021.08.003  0.771
2020 Rattagan M, De Francesco M, Kriebaum A, Ferraro F, Major C, Sharma D, Ojeda A, Martinez O, Musto AE. Cutis verticis gyrata: Two cases associated with drug-resistant epilepsy. Clinical Case Reports. 8: 1365-1368. PMID 32884755 DOI: 10.1002/Ccr3.2814  0.726
2018 Musto AE, Rutherford A, Malek D. Addressing Cultural Barriers to Diagnosis and Treatment of Epilepsy in Hispanic Communities. Jama Neurology. PMID 30534937 DOI: 10.1001/Jamaneurol.2018.3919  0.717
2018 Rana A, Musto AE. The role of inflammation in the development of epilepsy. Journal of Neuroinflammation. 15: 144. PMID 29764485 DOI: 10.1186/S12974-018-1192-7  0.775
2018 Britten RA, Jewell JS, Duncan VD, Hadley MM, Macadat E, Musto AE, La Tessa C. Impaired Attentional Set-Shifting Performance after Exposure to 5 cGy of 600 MeV/n 28Si Particles. Radiation Research. PMID 29309264 DOI: 10.1667/Rr14627.1  0.676
2018 Benfield J, Musto A. Intranasal Therapy to Stop Status Epilepticus in Prehospital Settings. Drugs in R&D. 18: 7-17. PMID 29177587 DOI: 10.1007/S40268-017-0219-3  0.476
2016 Musto AE, Rosencrans RF, Walker CP, Bhattacharjee S, Raulji CM, Belayev L, Fang Z, Gordon WC, Bazan NG. Corrigendum: Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Scientific Reports. 6: 32253. PMID 27586961 DOI: 10.1038/srep32253  0.734
2016 Musto AE, Rosencrans RF, Walker CP, Bhattacharjee S, Raulji CM, Belayev L, Fang Z, Gordon WC, Bazan NG. Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Scientific Reports. 6: 30298. PMID 27444269 DOI: 10.1038/Srep30298  0.781
2015 Musto AE, Walker CP, Petasis NA, Bazan NG. Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1. Plos One. 10: e0116543. PMID 25617763 DOI: 10.1371/Journal.Pone.0116543  0.8
2015 Bazan NG, Musto AE. What is the therapeutic potential of neuroprotectin D1 for epilepsy? Future Neurology. 10: 395-399. DOI: 10.2217/Fnl.15.25  0.772
2014 Marrero L, Wyczechowska D, Musto AE, Wilk A, Vashistha H, Zapata A, Walker C, Velasco-Gonzalez C, Parsons C, Wieland S, Levitt D, Reiss K, Prakash O. Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma. Neoplasia (New York, N.Y.). 16: 874-82. PMID 25379024 DOI: 10.1016/J.Neo.2014.08.015  0.705
2012 Prakash O, Lukiw WJ, Peruzzi F, Reiss K, Musto AE. Gliomas and seizures. Medical Hypotheses. 79: 622-6. PMID 22959996 DOI: 10.1016/J.Mehy.2012.07.037  0.759
2012 Addae C, Yi X, Gernapudi R, Cheng H, Musto A, Martinez-Ceballos E. All-trans-retinoid acid induces the differentiation of encapsulated mouse embryonic stem cells into GABAergic neurons Differentiation. 83: 233-241. PMID 22466603 DOI: 10.1016/J.Diff.2012.03.001  0.725
2012 Sfondouris JL, Quebedeaux TM, Holdgraf C, Musto AE. Combined process automation for large-scale EEG analysis. Computers in Biology and Medicine. 42: 129-34. PMID 22136696 DOI: 10.1016/J.Compbiomed.2011.10.017  0.729
2012 Musto A, Khoobehi K, Walker C, Bazan N. Neuroprotectin D1 Attenuates Epileptogenesis (S26.002) Neurology. 78: S26.002-S26.002. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S26.002  0.718
2012 Musto A, Khoobehi K, Walker C, Bazan N. Neuroprotectin D1 Attenuates Epileptogenesis (IN5-1.001) Neurology. 78: IN5-1.001-IN5-1.001. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In5-1.001  0.806
2011 Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Molecular Neurobiology. 44: 216-22. PMID 21918832 DOI: 10.1007/S12035-011-8200-6  0.758
2011 Musto AE, Gjorstrup P, Bazan NG. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia. 52: 1601-8. PMID 21569016 DOI: 10.1111/J.1528-1167.2011.03081.X  0.806
2011 Musto AE, Samii M. Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. Epilepsia. 52: 551-61. PMID 21204830 DOI: 10.1111/J.1528-1167.2010.02920.X  0.789
2009 Musto AE, Samii MS, Hayes JF. Different phases of afterdischarge during rapid kindling procedure in mice. Epilepsy Research. 85: 199-205. PMID 19375287 DOI: 10.1016/J.Eplepsyres.2009.02.020  0.757
2006 Cole-Edwards KK, Musto AE, Bazan NG. c-Jun N-terminal kinase activation responses induced by hippocampal kindling are mediated by reactive astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8295-304. PMID 16899724 DOI: 10.1523/Jneurosci.1986-05.2006  0.783
2006 Musto A, Bazan NG. Diacylglycerol kinase epsilon modulates rapid kindling epileptogenesis. Epilepsia. 47: 267-76. PMID 16499750 DOI: 10.1111/J.1528-1167.2006.00418.X  0.759
2005 Lukiw WJ, Cui JG, Musto AE, Musto BC, Bazan NG. Epileptogenesis in diacylglycerol kinase epsilon deficiency up-regulates COX-2 and tyrosine hydroxylase in hippocampus. Biochemical and Biophysical Research Communications. 338: 77-81. PMID 16137646 DOI: 10.1016/J.Bbrc.2005.08.109  0.761
2003 McDermott CM, LaHoste GJ, Chen C, Musto A, Bazan NG, Magee JC. Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9687-95. PMID 14573548 DOI: 10.1523/Jneurosci.23-29-09687.2003  0.734
2003 Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. The Journal of Biological Chemistry. 278: 43807-17. PMID 12923200 DOI: 10.1074/Jbc.M305841200  0.736
Show low-probability matches.